NEW YORK (GenomeWeb) – Bruker's board has authorized a share repurchase program, according to a document filed with the US Securities and Exchange Commission this week.

According to the firm's Form 8-K filed May 20, Bruker may repurchase shares of its common stock in order to offset the dilution of its stock resulting from the granting of option awards or restricted stock grants.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.